| Tag | Content |
|---|
EnhancerAtlas ID | HS108-30284 |
Organism | Homo sapiens |
Tissue/cell | K562 |
Coordinate | chr4:48730740-48731800 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| FOXA1 | MA0148.4 | chr4:48731225-48731241 | CACAGTGTAAACAAAG | + | 6 | | NFKB1 | MA0105.4 | chr4:48730963-48730976 | AGGGGATTTCCCT | + | 6.15 | | NFKB1 | MA0105.4 | chr4:48730963-48730976 | AGGGGATTTCCCT | - | 6.1 | | REL | MA0101.1 | chr4:48730964-48730974 | GGGGATTTCC | + | 6.02 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH04I048728 | chr4 | 48730801 | 48731901 |
|
Enhancer Sequence | AAACCATGAA AGTAAGAAGA GAGGGTTGCT TCCAAGATGG ACGAATAGTA ACAGCTCTGG 60
TCTGCAGCTC CCAGCAAGAT CAACGCAGAA GATGGTGATT TCTGCATTTC CAACTGAGGT 120
ACCTGGTACA TCTCACTGGG ACTGGTTGGA CAGTGGGTGC AGCCCACGGA GGGCAAGCCG 180
AAGCAGGGCA GGTCGTCACC TCACCTGGGA AATGCAAGCG GTCAGGGGAT TTCCCTTTCC 240
TAGCCAAGGG AAGCCGTGAG TGACTGTACC TGGAGGCGCA GTACACTCTT GCCTAAATAC 300
TGTGCTTTTC CCACGGTCTT CGCAACTGGC AGACCAGGAG ATCCCCTCCC GTGCCTGGCT 360
CAGCAGGTCC CATGCCCACG GAGCCTTGCT CACTGCTAGC GCAGCAGTCT GAGATTGACC 420
TGGGACGTGG GAGTTTGCTG AGGTGCATCT GCCACTGCTG ACACTTGAGT AGGTGGTTCT 480
ATGCTCACAG TGTAAACAAA GTGGCAAGGA AGCTCCAACT GGGCGGAGCC CACCACAGCT 540
CAGCAAGGCC TACTGCCTCT CTAGATTCCA CATCTGGGGA CAGGCCACGT CTGAATAAAA 600
GGCAGCAGAC AGCTTCTCCA GACTTAAATG TCCCTGTCTG ACAGCTCTGA AGAGAGCAGC 660
TGTTCTCCCA GCACGGTGTT CGAGCTCTGA TAACGGACAG ACTGCCTCCT CAAATGGGTC 720
TCTGACCCCT GTGTAGCCTG ACTGGAAGAC ACCTCTCAGT AGGGACTGAC AGACACCTCA 780
TACAGGCGGG TGCCTCTCTG GGACGAAGCT TCTAGAGGAA GGATCAGGCA GCAATATTTG 840
CTGTTCTACA GCCACCGCTG GTGAAACCCA GGCAAACAGG GTCTGGAGTG GACCTCCAGC 900
AAACTCCAAC ACATCTGCAG CTGAGGGGCC TATTAGAAGG AAAACTAATA AACAGAAAGG 960
AAGAGCATCA ACATCAACAA AAAAGACATA CCCACCAAAA CCCCATCCGT AGGTCACCAA 1020
CATCAAAGAC CAAAGGTAGA TAAAACCACA AAGATGGAGA 1060
|
